Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  • To determine whether corticosteroid therapy reduces the proportion of patients who die or have a poor outcome at one and six months after the onset of SAH or PICH.

  • To determine whether corticosteroid therapy reduces the frequency of DCI in patients with SAH.

  • To determine the frequency of adverse effects of corticosteroid therapy in patients with SAH and PICH within six months of the onset of the event.